Elanco to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Rhea-AI Summary

Elanco Animal Health (NYSE:ELAN) announced its participation in the upcoming Morgan Stanley 23rd Annual Global Healthcare Conference, scheduled for September 8-9, 2025. The company's leadership, including President and CEO Jeff Simmons and EVP and CFO Bob VanHimbergen, will engage in a fireside chat on September 9 at 8:30 a.m. ET.

Investors can access a live audio webcast through the "Events and Presentations" section of Elanco's investor website, with a replay available for a limited time after the event.

News Market Reaction – ELAN

+0.62%

7 alerts

+0.62% Session close to close

+2.3% Peak in 11 min

$8.89B Market Cap

0.5x Rel. Volume

In the Aug 26 session, ELAN gained 0.62%, reflecting a mild positive market reaction. Argus tracked a peak move of +2.3% during that session. Our momentum scanner triggered 7 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

GREENFIELD, Ind., Aug. 26, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Morgan Stanley 23^rd Annual Global Healthcare Conference, September 8-9, 2025. Jeff Simmons, President and CEO, and Bob VanHimbergen, Executive Vice President and CFO, will participate in a fireside chat on Tuesday, September 9 at 8:30 a.m. ET.

A live audio webcast will be available in the "Events and Presentations" section of Elanco's investor website. A replay will be available for a limited time at the conclusion of the event.

ABOUT ELANCO
Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders and society as a whole. With 70 years of animal health heritage, we are committed to breaking boundaries and going beyond to help our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our purpose – all to Go Beyond for Animals, Customers, Society and Our People. Learn more at www.elanco.com.

Investor Contact: Tiffany Kanaga (765) 740-0314 tiffany.kanaga@elancoah.com
Media Contact: Colleen Parr Dekker (317) 989-7011 colleen.dekker@elancoah.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/elanco-to-participate-in-morgan-stanley-23rd-annual-global-healthcare-conference-302538103.html

SOURCE Elanco Animal Health

FAQ

When is Elanco (NYSE:ELAN) presenting at the Morgan Stanley Healthcare Conference 2025?

Elanco will participate in a fireside chat on Tuesday, September 9, 2025 at 8:30 a.m. ET.

Who will represent Elanco at the Morgan Stanley Healthcare Conference 2025?

Jeff Simmons (President and CEO) and Bob VanHimbergen (Executive Vice President and CFO) will represent Elanco.

How can investors access Elanco's Morgan Stanley conference presentation?

Investors can access the live audio webcast through the 'Events and Presentations' section of Elanco's investor website. A replay will be available for a limited time after the event.

What is the duration of the Morgan Stanley Healthcare Conference 2025?

The Morgan Stanley 23rd Annual Global Healthcare Conference runs from September 8-9, 2025.